3Mixtatin and MTA Vital Pulpotomy in Primary Molars (NCT06478940) | Clinical Trial Compass
Not Yet RecruitingPhase 1
3Mixtatin and MTA Vital Pulpotomy in Primary Molars
50 participantsStarted 2024-08-01
Plain-language summary
The aim of the study is to evaluate clinical and radiographic success of using 3Mixtain versus mineral trioxide aggregate in pulpotomy of deeply carious Primary molars.
Who can participate
Age range
4 Years – 8 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* • Children 4-8 years old
* Vital deeply carious primary molars.
* No history of spontaneous pain, pathologic mobility, draining sinus tract, redness or swelling of the vestibule.
* Normal gingival and periodontal condition, with no sensitivity to vestibular palpation, and no pain on percussion test.
* Patient and parent showing cooperation and compliance.
Exclusion Criteria:
* • Uncooperative children to avoid time waste and attrition bias.
* Unrestorable molars
* Sign of radiolucency in periapical or furcation area
* Widening of PDL space or loss of lamina dura continuity
* Evidence of internal/external pathologic root resorption
* During operative procedure, when hemorrhage control is not achievable after pulpotomy.
* Children with systemic disease as some systemic diseases may have effect on the outcome.
* Unable to attend follow-up visits to avoid attrition bias by decreasing number of drop off cases.
* Refusal of participation as the parent of child has the authority of participation.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.